Clinical pathways for inborn errors of metabolism: warranted and feasible
Demirdas Serwet, van Kessel Imke N, Korndewal Marjolein J and 6 more
Orphanet Journal of Rare Diseases · 2013
doi:10.1186/1750-1172-8-37 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Inborn errors of metabolism (IEMs) are known for their low prevalence and multidisciplinary care mostly founded on expert opinion. Clinical pathways are multidisciplinary tools to organise care which provide a clear route to the best care and improve communication. In 2010 the Dutch Society for Children and Adults with an Inborn Error of Metabolism (VKS) initiated development of clinical pathways for inborn errors of metabolism. In this letter to the editor we describe why it is warranted to develop clinical pathways for IEMs and shortly discuss the process of development for these pathways in the Netherlands.
Abstract licence: CC BY
References16
- 15.
15 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.